Simvastatin and oxidative stress in humans: A randomized, double-blinded, placebo-controlled clinical trial

Simvastatin reduces the blood concentration of cholesterol by inhibiting hydroxymethylglutaryl-coenzyme A reductase, the rate-limiting enzyme in cholesterol synthesis, and thereby reduces the risk of cardiovascular disease. In addition, simvastatin treatment leads to a reduction in fluxes in mitocho...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasmussen, Sanne Tofte, Andersen, Jon Trærup, Nielsen, Torben Kjær, Cejvanovic, Vanja, Petersen, Kasper Meidahl, Henriksen, Trine, Weimann, Allan, Lykkesfeldt, Jens, Poulsen, Henrik Enghusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906137/
https://www.ncbi.nlm.nih.gov/pubmed/27281490
http://dx.doi.org/10.1016/j.redox.2016.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906137/
https://www.ncbi.nlm.nih.gov/pubmed/27281490
http://dx.doi.org/10.1016/j.redox.2016.05.007

Ejemplares similares